Information Provided By:
Fly News Breaks for October 11, 2018
ATRC
Oct 11, 2018 | 05:24 EDT
Piper Jaffray analyst Matt O'Brien says AtriCure's recent 2.5M share secondary offering cleans up the balance sheet and brings flexibility for business needs. The analyst would not be surprised to see 2018 numbers came in ahead of expectations and views the stock's current valuation as "reasonable." O'Brien encourages investors to start positions at current levels and keeps an Overweight rating on AtriCure with a $36 price target.
News For ATRC From the Last 2 Days
There are no results for your query ATRC
I agree to the thefly.com's disclaimer & terms of use
About Privacy Terms of Use

© 1996-2018 TheStreet, Inc., 14 Wall Street, 15th Fl, NY, NY 10005

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.